Salvage treatment options for prostate cancer after the failure of radiation as a primary treatment is often seen as a reason to avoid radiation as a primary treatment modality. The common collective wisdom is that after failed radiation our options for additional treatment of recurrent prostate cancer are limited to systematic treatments, hormone therapy, Ketoconazole [...]
HIFU is becoming increasing popular as a primary alternative treatment for men diagnosed with prostate cancer that is confined in the gland. Commonly used in Europe and in Mexico, HIFU is also being evaluated in a clinical trials in the United States. As with all primary prostate cancer treatments, it too has a failure rate. [...]
CAUTION, some doctors use estrogen patches as a form of first line hormone blockade therapy for the treatment of prostate cancer. However, scientists from Weill Cornell Medical College, New York City have described the hormone estrogen as a potential key negative player in about half of all prostate cancers. Researchers have found that Estrogen-linked signaling [...]
Two studies presented at the 103rd Annual Scientific Meeting of the American Urological Association (AUA), show that patients with incontinence resulting from iatrogenic sphincter damage may benefit from stem cell therapy. Incontinence after a radical prostatectomy for the treatment of prostate cancer can be a result in damage to the external urinary sphincter and would [...]
The FDA has announced its conditional approval, pending minor changes to the protocol, for a clinical trial for the treatment of recurrent prostate cancer with the Sonablate(R) 500 (HIFU) in men who have failed external beam radiation therapy. Dr. Herbert Lepor, Chairman of Urology at NYU School of Medicine will serve as the medical monitor [...]